These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26881860)

  • 61. Tics, anxiety, and possible PANDAS in an adolescent.
    Coffey B; Wieland N
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):533-8. PubMed ID: 17822348
    [No Abstract]   [Full Text] [Related]  

  • 62. [Risperidone use in child and adolescent psychiatric patients].
    Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
    Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder.
    Sayyah M; Boostani H; Pakseresht S; Malayeri A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):362-5. PubMed ID: 20035818
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Musical obsession or pseudohallucination: electrophysiological standpoint.
    Praharaj SK; Goyal N; Sarkar S; Bagati D; Sinha P; Sinha VK
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):230-4. PubMed ID: 19335393
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment outcome of schizophrenia co-morbid with obsessive-compulsive disorder.
    Sayeed Khan MN; Arshad N; Ullah N
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):234-6. PubMed ID: 15228829
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.
    Heiden A; de Zwaan M; Frey R; Presslich O; Kasper S
    J Psychiatry Neurosci; 1998 May; 23(3):179-80. PubMed ID: 9595892
    [No Abstract]   [Full Text] [Related]  

  • 67. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB
    J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Open trial of fluoxetine in obsessive-compulsive disorder.
    Jenike MA; Buttolph L; Baer L; Ricciardi J; Holland A
    Am J Psychiatry; 1989 Jul; 146(7):909-11. PubMed ID: 2787123
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of fluoxetine for obsessive-compulsive behavior in adults with autism.
    Koshes RJ
    Am J Psychiatry; 1997 Apr; 154(4):578. PubMed ID: 9090351
    [No Abstract]   [Full Text] [Related]  

  • 71. Treatment-resistant self-mutilation, tics, and obsessive-compulsive disorder in neuroacanthocytosis: a mouth guard as a therapeutic approach.
    Fontenelle LF; Leite MA
    J Clin Psychiatry; 2008 Jul; 69(7):1186-7. PubMed ID: 18687019
    [No Abstract]   [Full Text] [Related]  

  • 72. Fluoxetine-induced Raynaud's phenomenon.
    Rudnick A; Modai I; Zelikovski A
    Biol Psychiatry; 1997 Jun; 41(12):1218-21. PubMed ID: 9171912
    [No Abstract]   [Full Text] [Related]  

  • 73. Antidepressant use in bipolar disorder: continuing an age-old debate.
    Eppel A
    Am J Psychiatry; 2010 Nov; 167(11):1408; author reply 1408-9. PubMed ID: 21041258
    [No Abstract]   [Full Text] [Related]  

  • 74. Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders.
    Kim D; Ryba NL; Kalabalik J; Westrich L
    Drugs R D; 2018 Sep; 18(3):167-189. PubMed ID: 30171515
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder.
    Coric V; Milanovic S; Wasylink S; Patel P; Malison R; Krystal JH
    Psychopharmacology (Berl); 2003 May; 167(2):219-20. PubMed ID: 12658528
    [No Abstract]   [Full Text] [Related]  

  • 76. Fluoxetine in the treatment of Huntington's disease.
    De Marchi N; Daniele F; Ragone MA
    Psychopharmacology (Berl); 2001 Jan; 153(2):264-6. PubMed ID: 11205429
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Antipsychotics: treatment of schizophrenia and other therapeutic options].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10):74-78. PubMed ID: 31793547
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diagnosis and treatment of obsessive compulsive behavior in a boy with Duchenne muscular dystrophy and autism spectrum disorder: A case report.
    Hendriksen JG; Klinkenberg S; Collin P; Wong B; Niks EH; Vles JS
    Neuromuscul Disord; 2016 Oct; 26(10):659-661. PubMed ID: 27612598
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of comorbid bipolar disorder and anxiety disorders: A great challenge to modern psychiatry.
    Amerio A; Tonna M; Odone A; Stubbs B; Ghaemi SN
    Aust N Z J Psychiatry; 2016 Jul; 50(7):699-700. PubMed ID: 26619897
    [No Abstract]   [Full Text] [Related]  

  • 80. Obsessive-Compulsive Symptoms Associated With Aripiprazole Treatment in Bipolar Disorder: A Case Report.
    Gupta P; Gupta R; Balhara YP
    J Clin Psychopharmacol; 2017 Feb; 37(1):108-109. PubMed ID: 27930496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.